Further evidence for a peripheral component in the enhanced antinociceptive effect of systemic morphine in mononeuropathic rats: involvement of -, but not -opioid receptors

By Catheline G.   Kayser V.   Guilbaud G.  

European Journal of Pharmacology, Vol. 315, Iss. 2, 1996-11 ,pp. : 135-143

Elsevier

Access to resources Recommend Favorite

Effects of U-69,593, a -opioid receptor agonist, on carrageenin-induced peripheral oedema and Fos expression in the rat spinal cord

By Catheline G.   Le Guen S.   Besson J.-M.  

European Journal of Pharmacology, Vol. 370, Iss. 3, 1999-04 ,pp. : 287-296

Elsevier

Access to resources Recommend Favorite

Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats

By Perreault Melissa   Graham Dawn   Scattolon Sarah   Wang Yufang   Szechtman Henry   Foster Jane  

Psychopharmacology, Vol. 194, Iss. 4, 2007-11 ,pp. : 485-496

Springer Publishing Company

Access to resources Recommend Favorite

Sensitization to the conditioned rewarding effects of morphine and cocaine: differential effects of the -opioid receptor agonist U69593

By Shippenberg T.S.   LeFevour A.   Thompson A.C.  

European Journal of Pharmacology, Vol. 345, Iss. 1, 1998-03 ,pp. : 27-34

Elsevier

Access to resources Recommend Favorite

Antinociceptive effect of a -opioid receptor agonist that minimally crosses the blood-brain barrier (ICI 204448) in a rat model of mononeuropathy

By Keita H.   Kayser V.   Guilbaud G.  

European Journal of Pharmacology, Vol. 277, Iss. 2, 1995-04 ,pp. : 275-280

Elsevier

Access to resources Recommend Favorite